Complete this form to download.

Oncology Landscape: Current State and Future Trends

An aging population and growing number of cancer survivors are expected to increase demand for cancer services. This demand, coupled to an ongoing shift in care to the outpatient setting, a greater focus on value based care, and the need for care coordination will continue to influence how and where care is delivered. Health systems able to adapt to changes in innovation and care delivery will be best positioned to identify and capitalize on future growth opportunities. Featuring Sg2’s Impact of Change® forecast, case studies from providers, and strategies for cancer programs this webinar will highlight some of the key drivers impacting the future of cancer care delivery.

Remus-crop.png

Tim Remus, PhD

Consultant, SG2

As director of the cancer service line team, Tim leads the development and delivery of Sg2’s cancer intelligence and is the expert advisor for all oncology-related consulting projects. His team is responsible for developing the publications, webinars, web postings, analytic deliverables and strategic insights that provide clients with an understanding of key trends as they prepare for the changing cancer care environment. Tim also works with the technology and innovation team tracking advancements in current/innovative medical and imaging devices and assisting health care executives make decisions around technology acquisition and adoption.

Tim helps organize Sg2’s annual AMC Summit conference and is a frequent speaker at client education and leadership sessions, and other Sg2 events. He has also presented on health care trends at local and national conferences.

Prior to joining Sg2, Tim managed publication strategy for pharmaceutical and medical device companies and published the results from ongoing and completed clinical trials. He also led speaker training events and developed materials designed to educate physicians on new drug therapies and disease states. Tim has extensive experience working in the fields of oncology, depression, hemostasis and diabetes.

Tim earned a PhD in molecular and cellular biochemistry from Loyola University Chicago. His work was published in scientific journals and presented at local, national and international scientific conferences. He graduated from Marquette University with
a BS in biochemistry.